Transasia Bio-Medicals names Medtronic biz director Ravi Kaushik as new CEO

Published On 2019-12-11 03:47 GMT   |   Update On 2019-12-11 03:47 GMT

Prior to this appointment at Transasia Bio-Medicals, Ravi Kaushik was Group Marketing Director - Asia Pacific & Country Business Director - Diabetes (Indian Sub-continent) at Medtronic.


New Delhi: In-vitro diagnostic firm Transasia Bio-Medicals on Tuesday announced the appointment of Ravi Kaushik as its chief executive officer.


The company has also appointed Bhupendra Chaudhary as President - Sales and Marketing, Transasia Bio-Medicals said in a statement.


Prior to this appointment, Kaushik was Group Marketing Director - Asia Pacific & Country Business Director - Diabetes (Indian Sub-continent) at Medtronic.


Also Read: Solara Active Pharma names Bharath R Sesha as new CEO


Ravi Chaudhary's earlier stint was with Entero Healthcare Solutions as President - Medical Devices & Consumables, it added.


"As we ready ourselves to emerge as among the top 10 IVD players in the world focused on emerging markets, it was imperative that we strengthened our leadership team further," Transasia Bio-Medicals Chairman & MD Suresh Vazirani said.


The two appointees bring diverse and relevant experience in new product development, strategic planning, business model innovation and regulatory approval, among others, he added.


Also Read: Biocon names Siddharth Mittal as new CEO, Joint MD; bids farewell to Arun Chandavarkar

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News